XML 130 R60.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-based compensation expense and income tax benefits recognized during the periods
The following table provides information on share-based compensation expense and income tax benefits recognized in 2013, 2012 and 2011:
 
 
Years ended December 31,
 
 
2013
 
2012
 
2011
 
 
(In thousands)
Stock option and stock purchase plans
 
$
8,303

 
9,469

 
9,497

Nonvested stock
 
11,007

 
9,395

 
7,926

Share-based compensation expense
 
19,310

 
18,864

 
17,423

Income tax benefit
 
(6,224
)
 
(6,309
)
 
(5,794
)
Share-based compensation expense, net of tax
 
$
13,086

 
12,555

 
11,629

Summary of share-based compensation expense recognized related to cash awards
The following table is a summary of compensation expense recognized related to cash awards in addition to share-based compensation expense reported in the previous table.
 
 
Years ended December 31
 
 
2013
 
2012
 
2011
 
 
(In thousands)
Cash awards
 
$
996

 
1,099

 
1,882

Summary of stock option activity
The following is a summary of option activity under our stock option plans as of and for the year ended December 31, 2013:
 
 
Shares
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic  Value
 
 
(In thousands)
 
 
 
(In years)
 
(In thousands)
Options outstanding at January 1
 
3,148

 
$
46.36

 
 
 
 
Granted
 
391

 
58.27

 
 
 
 
Exercised
 
(1,730
)
 
45.28

 
 
 
 
Forfeited or expired
 
(92
)
 
49.56

 
 
 
 
Options outstanding at December 31
 
1,717

 
$
49.99

 
4.9
 
$
40,861

Vested and expected to vest at December 31
 
1,653

 
$
49.75

 
4.5
 
$
39,730

Exercisable at December 31
 
889

 
$
45.34

 
3.2
 
$
25,285

Information about options in various price ranges
Information about options in various price ranges at December 31, 2013 follows:
 
 
Options Outstanding
 
Options Exercisable
Price Ranges
 
Shares
 
Weighted-
Average
Remaining
Contractual
Term
 
Weighted-
Average  Exercise
Price
 
Shares
 
Weighted-
Average  Exercise
Price
 
 
(In thousands)
 
(In years)
 
 

 
(In thousands)
 
 
Less than $45.00
 
354
 
2.9
 
$
33.14

 
354
 
$
33.14

45.00-50.00
 
412
 
4.1
 
49.39

 
254
 
49.39

50.00-55.00
 
413
 
4.9
 
53.57

 
128
 
53.47

55.00 and over
 
538
 
6.9
 
58.79

 
153
 
60.07

Total
 
1,717
 
4.9
 
$
49.99

 
889
 
$
45.34

Summary of Nonvested stock awards
The following is a summary of the status of Ryder’s nonvested restricted stock awards as of and for the year ended December 31, 2013:
 
 
Time-Vested
 
Market-Based Vested
 
Performance-Based Vested
 
 
Shares
 
Weighted-
Average
Grant Date
Fair Value
 
Shares
 
Weighted-
Average
Grant Date
Fair Value
 
Shares
 
Weighted-
Average
Grant Date
Fair Value
 
 
(In thousands)
 
 
 
(In thousands)
 
 
 
(In thousands)
 
 
Nonvested stock outstanding at January 1
 
440
 
$
49.16

 
387
 
$
25.35

 
 
$

Granted
 
162
 
58.39

 
23
 
53.66

 
16
 
58.27

Vested
 
(58)
 
40.19

 
 

 
 

Forfeited
 
(10)
 
58.85

 
(205)
 
20.19

 
(1)
 
58.21

Nonvested stock outstanding at December 31
 
534
 
$
52.58

 
205
 
$
33.71

 
15
 
$
58.27

Summary of Employee Stock Purchase Plan
The following table summarizes the status of Ryder’s ESPP:
 
 
Shares
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic  Value
 
 
(In thousands)
 
 
 
(In years)
 
(In thousands)
Outstanding at January 1
 
 
$

 
 
 
 
Granted
 
194
 
48.72

 
 
 
 
Exercised
 
(194)
 
48.72

 
 
 
 
Forfeited or expired
 
 

 
 
 
 
Outstanding at December 31
 

 
$

 

 
$

Exercisable at December 31
 

 
$

 

 
$

Weighted-average assumptions used for options granted
The following table presents the weighted-average assumptions used for options granted:
 
 
Years ended December 31,
  
 
2013
 
2012
 
2011
Option plans:
 
 
 
 
 
 
Expected dividends
 
2.1%
 
2.2%
 
2.2%
Expected volatility
 
35.1%
 
40.7%
 
38.7%
Risk-free rate
 
0.7%
 
0.6%
 
1.7%
Expected term in years
 
4.3 years
 
3.7 years
 
3.6 years
Grant-date fair value
 
$13.97
 
$14.07
 
$12.88
Purchase plan:
 
 
 
 
 
 
Expected dividends
 
2.2%
 
2.7%
 
2.4%
Expected volatility
 
28.0%
 
32.7%
 
32.8%
Risk-free rate
 
0.1%
 
0.1%
 
0.1%
Expected term in years
 
0.25 years
 
0.25 years
 
0.25 years
Grant-date fair value
 
$11.73
 
$9.53
 
$10.21